ATE376555T1 - Estrieno(3,2-b)/(3,4-c)pyrrole derivative als modulatoren des östrogen rezeptors - Google Patents

Estrieno(3,2-b)/(3,4-c)pyrrole derivative als modulatoren des östrogen rezeptors

Info

Publication number
ATE376555T1
ATE376555T1 AT03763151T AT03763151T ATE376555T1 AT E376555 T1 ATE376555 T1 AT E376555T1 AT 03763151 T AT03763151 T AT 03763151T AT 03763151 T AT03763151 T AT 03763151T AT E376555 T1 ATE376555 T1 AT E376555T1
Authority
AT
Austria
Prior art keywords
estrieno
estrogen receptor
modulators
pyrrole derivatives
pyrrole
Prior art date
Application number
AT03763151T
Other languages
English (en)
Inventor
Zhihua Sui
Xuqing Zhang
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE376555T1 publication Critical patent/ATE376555T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT03763151T 2002-07-03 2003-07-02 Estrieno(3,2-b)/(3,4-c)pyrrole derivative als modulatoren des östrogen rezeptors ATE376555T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39360802P 2002-07-03 2002-07-03

Publications (1)

Publication Number Publication Date
ATE376555T1 true ATE376555T1 (de) 2007-11-15

Family

ID=30115610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03763151T ATE376555T1 (de) 2002-07-03 2003-07-02 Estrieno(3,2-b)/(3,4-c)pyrrole derivative als modulatoren des östrogen rezeptors

Country Status (12)

Country Link
EP (1) EP1606307B1 (de)
JP (1) JP2005537256A (de)
CN (1) CN100345863C (de)
AT (1) ATE376555T1 (de)
AU (1) AU2003251768A1 (de)
CA (1) CA2491132A1 (de)
CY (1) CY1107145T1 (de)
DE (1) DE60317109T2 (de)
DK (1) DK1606307T3 (de)
ES (1) ES2295645T3 (de)
PT (1) PT1606307E (de)
WO (1) WO2004005314A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2000351C2 (nl) 2005-12-22 2007-09-11 Pfizer Prod Inc Estrogeen-modulatoren.
EP2147924A1 (de) * 2008-07-24 2010-01-27 Bayer Schering Pharma Aktiengesellschaft Estratrien-Derivate mit heterozyklischen Bioisosteren für den Phenol-A-Ring
WO2011092127A1 (en) 2010-01-26 2011-08-04 Bayer Schering Pharma Aktiengesellschaft 14,17-bridged estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3484435A (en) * 1965-08-23 1969-12-16 Ormonoterapia Richter Spa Estra-triene-pyrazoles and a method for their preparation

Also Published As

Publication number Publication date
PT1606307E (pt) 2007-11-21
CN1678626A (zh) 2005-10-05
ES2295645T3 (es) 2008-04-16
DK1606307T3 (da) 2008-01-21
JP2005537256A (ja) 2005-12-08
CY1107145T1 (el) 2012-10-24
CA2491132A1 (en) 2004-01-15
DE60317109T2 (de) 2008-07-31
DE60317109D1 (de) 2007-12-06
AU2003251768A1 (en) 2004-01-23
EP1606307A1 (de) 2005-12-21
WO2004005314A1 (en) 2004-01-15
CN100345863C (zh) 2007-10-31
EP1606307B1 (de) 2007-10-24

Similar Documents

Publication Publication Date Title
MY137053A (en) Pyrimidine derivatives and their use as cb2 modulators
AU2003276028A1 (en) Pyridine derivatives as cb2 receptor modulators
BRPI0513899A (pt) moduladores de cinase heterocìclica de anel fundido
ATE449090T1 (de) Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
NI200700163A (es) Moduladores tricíclicos de delta-opioide
BG108660A (en) Pyrrolidinone derivatives
TW200503705A (en) 3-amino chroman and 2-amino tetralin derivatives
MX2007007103A (es) Derivados espiro como inhibidores de lipoxigenasa.
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
MXPA06003363A (es) Derivados de fenil-piperazina como moduladores de receptores muscarinicos.
ATE543813T1 (de) Neue benzopyranderivate als kaliumkanalöffner
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
ES2328496T3 (es) Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos.
NI200700030A (es) Moduladores tricíclicos del delta-opioide
DE60018213D1 (de) Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons
ATE359782T1 (de) Heteroaryl-substituierte pyrrol(2, 3- b)pyridin- derivate als crf-rezeptor-antagonisten
DE60221425D1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase-inhibitoren
MX2007007627A (es) Moduladores delta-opioides triciclicos.
CY1107145T1 (el) Παραγωγα εστριενο[3,2-b]/[3,4-c]πυρρολης χρησιμα ως ρυθμιστες των υποδοχεων οιστρογονων
ATE373644T1 (de) N-substituierte 3-hydroxy-4-pyridinone und diese enthaltende pharmazeutika
WO2005000775A3 (en) Cyclohexyl derivatives as selective estrogen receptor modulators
DE602005010735D1 (de) Neue 2h-chromenderivate als selektive östrogenrezeptor-modulatoren
ATE355287T1 (de) 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1606307

Country of ref document: EP

REN Ceased due to non-payment of the annual fee